Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer

By Schirrmeister Holger   Arslandemir Coskun   Glatting Gerhard   Mayer-Steinacker Regine   Bommer Martin   Dreinhöfer Karsten   Buck Andreas   Hetzel Martin  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 31, Iss. 7, 2004-07 ,pp. : 964-968

Springer Publishing Company

Access to resources Recommend Favorite

FDG PET for staging of advanced non-small cell lung cancer prior to neoadjuvant radio-chemotherapy

By Eschmann S.   Friedel G.   Paulsen F.   Budach W.   Harer-Mouline C.   Dohmen B.   Bares R.  

European Journal of Nuclear Medicine and Molecular Imaging, Vol. 29, Iss. 6, 2002-06 ,pp. : 804-808

Springer Publishing Company

Access to resources Recommend Favorite

Molecular imaging for detection of sensitivity and resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer

By Iommelli F.   De Rosa V.   Fonti R.   Del Vecchio S.  

Clinical and Translational Imaging, Vol. 2, Iss. 1, 2014-02 ,pp. : 43-53

Springer Publishing Company

Access to resources Recommend Favorite

Lung pathology: The molecular genetics of non-small cell lung cancer

By Fong Kwun   Zimmerman Paul   Smith Peter  

Pathology, Vol. 27, Iss. 4, 1995-10 ,pp. : 295-301

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Value of FDG-PET in the management of non-small cell lung cancer

By Stroobants S.   Verschakelen J.   Vansteenkiste J.  

European Journal of Radiology, Vol. 45, Iss. 1, 2003-01 ,pp. : 49-59

Elsevier

Access to resources Recommend Favorite